Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP6294 in Female Subjects With Bladder Pain Syndrome/Interstitial Cystitis
NCT03282318Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Sep 2017
- Primary completion
- Mar 2019
- Modality
- Antibody Conjugates, Fab Fragments, Monoclonal Antibodies
- Countries
- 10
01
Overview
A Phase 2 trial of ASP6294 in bladder pain syndrome (BPS), sponsored by Astellas Pharma. Started Sep 2017; status: completed.
02
Drugs
ASP6294
03
Conditions
bladder pain syndrome (BPS)
Beyond the preview
Go deeper on NCT03282318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03282318.